Efficacy and safety of octanorm (cutaquig ®) in adults with primary immunodeficiencies with predominant antibody deficiency: a prospective, open-label study

Immunotherapy, Ahead of Print.

Source: Immunotherapy - March 25, 2020 Category: Allergy & Immunology Authors: Elena Latysheva Yulia Rodina Liudmila Sizyakina Areg Totolian Irina Tuzankina Source Type: research